Stock Analysis

Fidia First Half 2024 Earnings: €0.21 loss per share (vs €0.30 loss in 1H 2023)

Published
BIT:FDA

Fidia (BIT:FDA) First Half 2024 Results

Key Financial Results

  • Revenue: €9.42m (up 4.8% from 1H 2023).
  • Net loss: €7.22m (loss widened by 246% from 1H 2023).
  • €0.21 loss per share.
BIT:FDA Earnings and Revenue History October 26th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Fidia shares are down 18% from a week ago.

Risk Analysis

Before we wrap up, we've discovered 3 warning signs for Fidia that you should be aware of.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.